Kura Oncology, Inc. (KURA)
10.65
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
10.72
+0.07
(+0.66%)
Pre-Market: 20:00
Kura Oncology Market Cap : 947.36M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 947.36M |
| October 01, 2026 | 947.36M |
| September 30, 2026 | 952.70M |
| September 29, 2026 | 961.15M |
| September 28, 2026 | 943.80M |
| September 25, 2026 | 957.14M |
| September 24, 2026 | 966.04M |
| September 23, 2026 | 982.05M |
| September 22, 2026 | 1.043B |
| September 21, 2026 | 1.032B |
| September 18, 2026 | 1.043B |
| September 17, 2026 | 1.043B |
| September 16, 2026 | 996.28M |
| September 15, 2026 | 1.005B |
| September 14, 2026 | 1.028B |
| September 11, 2026 | 1.013B |
| September 10, 2026 | 1.029B |
| September 09, 2026 | 1.075B |
| September 08, 2026 | 1.114B |
| September 04, 2026 | 1.179B |
| September 03, 2026 | 1.170B |
| September 02, 2026 | 1.166B |
| September 01, 2026 | 1.147B |
| August 31, 2026 | 1.125B |
| August 28, 2026 | 1.126B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.172B |
| August 26, 2026 | 1.162B |
| August 25, 2026 | 1.209B |
| August 24, 2026 | 1.103B |
| August 21, 2026 | 1.058B |
| August 20, 2026 | 1.042B |
| August 19, 2026 | 1.115B |
| August 18, 2026 | 1.097B |
| August 17, 2026 | 1.003B |
| August 14, 2026 | 966.04M |
| August 13, 2026 | 897.55M |
| August 12, 2026 | 884.20M |
| August 11, 2026 | 883.31M |
| August 10, 2026 | 876.20M |
| August 07, 2026 | 849.46M |
| August 06, 2026 | 823.72M |
| August 05, 2026 | 816.62M |
| August 04, 2026 | 840.59M |
| August 03, 2026 | 815.73M |
| July 31, 2026 | 799.75M |
| July 30, 2026 | 826.38M |
| July 29, 2026 | 792.65M |
| July 28, 2026 | 826.38M |
| July 27, 2026 | 900.94M |
| July 24, 2026 | 922.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inovio Pharmaceuticals, Inc. | 95.52M |
| Fortress Biotech, Inc. | 67.62M |
| Spero Therapeutics, Inc. | 69.19M |
| Gossamer Bio, Inc. | 65.44M |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
Market Cap Related Metrics
| PS Ratio | 12.18 |
| PEG Ratio | -0.0648 |
| Price to Book Value | 19.56 |
| Price | 10.65 |
| Earnings Yield | -31.57% |
| PEGY Ratio | -0.0648 |